Puma Biotechnology (PBYI) Shares Soar On Breast Cancer Drug Results
Pfizer Inc. (PFE) Backs Out of Funding Puma Biotechnology (PBYI) Cancer Drug Trials
Biogen Idec, Inc. (Massachusetts) (BIIB) Second Quarter 2014 Revenues Increase 40% To $2.4 Billion; Company Raises Financial Guidance For The Year
Myriad RBM, Inc. To Downsize And Move Operations To Austin, Texas
ArmaGen Technologies, Inc. Licenses AGT-182 Rights To Shire For Up To $225M
U.S. FDA Approves Gilead Sciences, Inc. (GILD)'s Zydelig® (idelalisib) For Relapsed Chronic Lymphocytic Leukemia, Follicular Lymphoma And Small Lymphocytic Lymphoma
Mylan Inc. (MYL)'s Overseas Move Will Lower Tax Rate
Welichem Announces Termination Of Asset Purchase Agreement And Update On Compulsory Acquisition
FDA Approves Eagle Pharmaceuticals (EGRX)' Ryanodex® For The Treatment Of Malignant Hyperthermia
Health Canada Approves Kane Biotech Inc. (KNE)'s DispersinB® For Human Use
Sofinnova Ventures Raises $500 Million Biotech Venture Fund
Major Advance In UCB Pipeline: Positive Topline Phase 3 Results For brivaracetam In Epilepsy Patients With Partial-Onset Seizures
Taiho Pharmaceutical Invests US $30 Million In Remiges Biopharma Fund, LP
Shire Share Price: Chief Executive Set For $10 Million 'Golden Hello'
City To Give Biotech Firm Illumina, Inc. (ILMN) $1.5 Million In Tax Incentives Over 10 Years
ConMed Corporation (CNMD) Announces Leadership Transition
Zenith Epigenetics Appoints Julie Cherrington As President And CEO
Mela Sciences (MELA) Announces $27.3 Million Private Placement Of Preferred Stock, Debentures And Warrants
See All News >
Major Restructure At Allergan Inc. (AGN) Amid Valeant Pharmaceuticals International (VRX) Takeover Battle; Allergan Inc. To Cut 1,500 Jobs
Candid Advice For Cash-Strapped Startups From A Biotech VC; Success At Lumena Pharmaceuticals
Fall From Grace: BioSpace (DHX) Readers Sound Off On Novartis AG (NVS) And Other Pharma Layoffs
Aduro Biotech Receives Breakthrough Therapy Designation From FDA For Innovative Pancreatic Cancer Combination Immunotherapy
Johnson & Johnson (JNJ) CEO: We Have No Plans To Leave The U.S.
Roche (RHHBY) CEO Plans To Steer Clear Of Big Acquisitions
Anacor Pharmaceuticals, Inc. (ANAC) Inks Exclusive Deal With Sandoz, Inc. For Kerydin; Anacor To Receive Upfront $40 Million
Large Allergan Inc. (AGN) Investor Sells Most Of Stake
AbbVie (ABBV) Finally Clinches Shire For $54 Billion
Avid Cyclists Could Have Higher Prostate Cancer Risk, University College London Study
Catalent Pharma Solutions Sees IPO Of 42.5 Million Shares Priced Between $19-$22/Share
Vertex Pharmaceuticals Incorporated (VRTX)'s $300,000 A Year Drug Is Denied, And Medicaid Patients Sue
New Analysis Suggests Pricey Gilead Sciences, Inc. (GILD) Drug Will Bust State Budgets
AstraZeneca PLC (AZN) Unveils Plans For "See-Through" Labs In Cambridge
San Diego Biotech Pfenex Inc. Slashes Proposed Range To $8 A Share, Eyes $65 Million In IPO Debut
Johnson & Johnson (JNJ) Spinout Zosano Pharma, Inc. Sets Terms For $70 Million IPO
Novartis AG (NVS) Plant To Fall Under GlaxoSmithKline (GSK) Control
Vision Loss Associated With Employment Status, JAMA
See All News >